论文部分内容阅读
记者:陈总经理,您好。《中华人民共和国药品管理法实施条例》(以下简称《实施条例》)已于今年8月4日颁布,并于9月15日起开始实施。《实施条例》进一步加强了对药品生产、经营企业的管理,同时严格了对GMP、GSP的认证工作,以确保人民群众的用药安全有效。北京医药股份有限公司是集生产、经营、零售于一体的企业,您做为该企业的总经理,请您就条例谈谈您的看法。首先,请您谈谈《实施条例》的实施颁布对企业的意义是什么?
Reporter: Chen, general manager, hello. The Regulations for the Implementation of the Drug Administration Law of the People’s Republic of China (the “Implementation Regulations”) were promulgated on August 4 this year and will come into effect on September 15. The “Implementation Regulations” further strengthened the management of pharmaceutical production and operation of enterprises, and at the same time, strictly authenticated the GMP and GSP to ensure that people’s medicines were safe and effective. Beijing Pharmaceutical Co., Ltd. is a production, management, retail in one of the enterprises, you as the company’s general manager, please talk about your views on the Ordinance. First of all, please talk about the implementation of the “Regulations” promulgated what is the significance of the enterprise?